{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T18:53:02Z","timestamp":1785783182989,"version":"3.56.0"},"reference-count":211,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001230","name":"Macquarie University","doi-asserted-by":"publisher","award":["MQRF0001191-2022"],"award-info":[{"award-number":["MQRF0001191-2022"]}],"id":[{"id":"10.13039\/501100001230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1173363"],"award-info":[{"award-number":["APP1173363"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ijbiomac.2025.148663","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T01:13:19Z","timestamp":1761959599000},"page":"148663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P2","title":["Intranasal delivery of insulin: An update on status quo and challenges for diabetes treatment"],"prefix":"10.1016","volume":"332","author":[{"given":"Chun Yuen Jerry","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Baldelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"Tietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Leite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Xin","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Traini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0005","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.2337\/db10-1360","article-title":"Evidence that nasal insulin induces immune tolerance to insulin in adults with autoimmune diabetes","volume":"60","author":"Fourlanos","year":"2011","journal-title":"Diabetes"},{"issue":"11\u221212","key":"10.1016\/j.ijbiomac.2025.148663_bb0010","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.drudis.2010.03.011","article-title":"New strategies to improve the intranasal absorption of insulin","volume":"15","author":"Duan","year":"2010","journal-title":"Drug Discov. Today"},{"issue":"11\u201312","key":"10.1016\/j.ijbiomac.2025.148663_bb0015","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1159\/000504551","article-title":"Insulin action in the hypothalamus increases second-phase insulin secretion in humans","volume":"110","author":"Heni","year":"2020","journal-title":"Neuroendocrinology"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0020","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2337\/dc25-1640","article-title":"Global and regional prediabetes prevalence: updates for 2024 and projections for 2050","volume":"48","author":"Rooney","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0025","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfaf177","article-title":"IDF diabetes atlas 11th edition 2025: global prevalence and projections for 2050","author":"Duncan","year":"2025","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121068","article-title":"Strategies for the delivery of antidiabetic drugs via intranasal route","volume":"608","author":"Dholakia","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0035","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1208\/pt060227","article-title":"Insulin gel as an alternate to parenteral insulin: formulation, preclinical, and clinical studies","volume":"6","author":"D\u2019Souza","year":"2005","journal-title":"AAPS PharmSciTech"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0040","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: unraveling the potential for Alzheimer\u2019s disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0045","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.jconrel.2010.08.004","article-title":"Systemic delivery of insulin via the nasal route using a new microemulsion system: in vitro and in vivo studies","volume":"148","author":"Sintov","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121565","article-title":"Intranasal delivery of insulin by self-emulsified nanoemulsion system: in vitro and in vivo studies","volume":"616","author":"Shah","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0055","article-title":"A comprehensive review of intranasal insulin and its effect on the cognitive function of diabetics","volume":"13","author":"Gaddam","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118584","article-title":"Improving the hypoglycemic effect of insulin via the nasal administration of deep eutectic solvents","volume":"569","author":"Li","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148663_bb0065","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/jphp.13359","article-title":"C2C12 cell model: its role in understanding of insulin resistance at the molecular level and pharmaceutical development at the preclinical stage","volume":"72","author":"Wong","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2025.148663_bb0070","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0169-409X(98)00073-8","article-title":"Intranasal insulin delivery and therapy","volume":"35","author":"Hinchcliffe","year":"1999","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0075","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2165\/00003088-199223010-00003","article-title":"Intranasal insulin. Clinical pharmacokinetics","volume":"23","author":"Illum","year":"1992","journal-title":"Clin. Pharmacokinet."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0080","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2337\/diab.32.11.1040","article-title":"Insulin administered intranasally as an insulin\u2013bile salt aerosol. Effectiveness and reproducibility in normal and diabetic subjects","volume":"32","author":"Moses","year":"1983","journal-title":"Diabetes"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0085","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0159150","article-title":"Nasal absorption of macromolecules from powder formulations and effects of sodium carboxymethyl cellulose on their absorption","volume":"11","author":"Tanaka","year":"2016","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/10611860701453653","article-title":"Muco-adhesive multivesicular liposomes as an effective carrier for transmucosal insulin delivery","volume":"15","author":"Jain","year":"2007","journal-title":"J. Drug Target."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.xphs.2025.103795","article-title":"Intranasal delivery of temozolomide and desloratadine for brain tumour therapy: a cellular study on nasal epithelial toxicity, transport, and permeability","volume":"114","author":"Wong","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133437","article-title":"Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes","volume":"275","author":"Adwani","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0105","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijpharm.2005.10.016","article-title":"Thiolated chitosan microparticles: a vehicle for nasal peptide drug delivery","volume":"307","author":"Krauland","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0110","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/jpp.62.05.0004","article-title":"Nasal absorption and local tissue reaction of insulin nanocomplexes of trimethyl chitosan derivatives in rats","volume":"62","author":"Jintapattanakit","year":"2010","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0115","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1023\/A:1015867305641","article-title":"Bile salt\u2013fatty acid mixed micelles as nasal absorption promoters of peptides. II. In vivo nasal absorption of insulin in rats and effects of mixed micelles on the morphological integrity of the nasal mucosa","volume":"7","author":"Tengamnuay","year":"1990","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.nut.2009.08.001","article-title":"Inhaled insulin \u2013 intrapulmonary, intranasal, and other routes of administration: mechanisms of action","volume":"26","author":"Henkin","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jconrel.2018.08.042","article-title":"Preparation, properties and challenges of the microneedles-based insulin delivery system","volume":"288","author":"Chen","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101325","article-title":"Structural principles of insulin formulation and analog design: a century of innovation","volume":"52","author":"Jarosinski","year":"2021","journal-title":"Mol. Metab."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0135","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jps.10355","article-title":"Prediction of the association state of insulin using spectral parameters","volume":"92","author":"Uversky","year":"2003","journal-title":"J. Pharm. Sci."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0140","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1080\/1061186X.2020.1726356","article-title":"Cellular assays and applied technologies for characterisation of orally administered protein nanoparticles: a systematic review","volume":"28","author":"Wong","year":"2020","journal-title":"J. Drug Target."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0145","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1080\/1061186X.2020.1759078","article-title":"Current status and applications of animal models in pre-clinical development of orally administered insulin-loaded nanoparticles","volume":"28","author":"Wong","year":"2020","journal-title":"J. Drug Target."},{"issue":"27","key":"10.1016\/j.ijbiomac.2025.148663_bb0150","doi-asserted-by":"crossref","first-page":"6991","DOI":"10.1007\/s00216-018-1319-9","article-title":"Quantification of BSA-loaded chitosan\/oligonucleotide nanoparticles using reverse-phase HPLC","volume":"410","author":"Wong","year":"2018","journal-title":"Anal. Bioanal. Chem."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124009","article-title":"Nasal delivery of encapsulated recombinant ACE2 as a prophylactic drug for SARS-CoV-2","volume":"655","author":"Baldelli","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0160","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123922","article-title":"An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting","volume":"654","author":"Wong","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/2230-973X.176456","article-title":"Insulin delivery methods: past, present and future","volume":"6","author":"Shah","year":"2016","journal-title":"Int. J. Pharm. Investig."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0170","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","article-title":"Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs","volume":"281","author":"Agrawal","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0175","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ijbiomac.2022.01.134","article-title":"Recent progress in polymeric non-invasive insulin delivery","volume":"203","author":"Sabbagh","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0180","doi-asserted-by":"crossref","first-page":"240","DOI":"10.2174\/1389201015666140813125840","article-title":"CPP-mediated insulin delivery: current status and promising future","volume":"15","author":"Liu","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0185","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1111\/jphp.12607","article-title":"Oral delivery of insulin for treatment of diabetes: status quo, challenges and opportunities","volume":"68","author":"Wong","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0190","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/jphp.12694","article-title":"In-vitro evaluation of enteric coated insulin tablets containing absorption enhancer and enzyme inhibitor","volume":"69","author":"Wong","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0195","article-title":"Formulation and characterisation of insulin-loaded chitosan nanoparticles capable of inducing glucose uptake in skeletal muscle cells in vitro","volume":"57","author":"Wong","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0200","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1208\/s12249-020-01648-6","article-title":"Lyophilisation improves bioactivity and stability of insulin-loaded polymeric-oligonucleotide nanoparticles for diabetes treatment","volume":"21","author":"Wong","year":"2020","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118720","article-title":"Bio-nanotechnological advancement of orally administered insulin nanoparticles: comprehensive review of experimental design for physicochemical characterization","volume":"572","author":"Wong","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148663_bb0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijpharm.2005.10.049","article-title":"Influence of deposition and spray pattern of nasal powders on insulin bioavailability","volume":"310","author":"Pringels","year":"2006","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0215","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/jpp\/rgaa052","article-title":"\u03b2-Cyclodextrin-containing chitosan\u2013oligonucleotide nanoparticles improve insulin bioactivity, gut cellular permeation and glucose consumption","volume":"73","author":"Wong","year":"2021","journal-title":"J. Pharm. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0220","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1080\/1061186X.2020.1817042","article-title":"Fabrication techniques for the preparation of orally administered insulin nanoparticles","volume":"29","author":"Wong","year":"2021","journal-title":"J. Drug Target."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0225","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1080\/03639045.2020.1788061","article-title":"Development of orally administered insulin-loaded polymeric\u2013oligonucleotide nanoparticles: statistical optimization and physicochemical characterization","volume":"46","author":"Wong","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0230","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/MJT.0000000000001076","article-title":"Insulin therapy: future perspectives","volume":"27","author":"Cernea","year":"2020","journal-title":"Am. J. Ther."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0235","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.3390\/pharmaceutics13111904","article-title":"Selective CNS targeting and distribution with a refined region-specific intranasal delivery technique via the olfactory mucosa","volume":"13","author":"Maigler","year":"2021","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124743","article-title":"Anatomically-detailed segmented representative adult and pediatric nasal models for assessing regional drug delivery and bioequivalence with suspension nasal sprays","volume":"666","author":"Khadka","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0245","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4155\/tde.12.120","article-title":"Towards the nasal delivery of insulin","volume":"3","author":"Nazar","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0250","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3389\/fphar.2017.00706","article-title":"Targeting mediators of smoking persistence with intranasal insulin","volume":"8","author":"Hamidovic","year":"2017","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0255","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1021\/acsabm.0c00002","article-title":"Internalization mechanism of phenylboronic-acid-decorated nanoplatform for enhanced nasal insulin delivery","volume":"3","author":"Wei","year":"2020","journal-title":"ACS Appl. Bio Mater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0260","first-page":"188","article-title":"Development and characterization of in situ gel system for nasal insulin delivery","volume":"65","author":"Agrawal","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0265","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jconrel.2017.11.040","article-title":"Nose-to-brain delivery of insulin enhanced by a nanogel carrier","volume":"270","author":"Picone","year":"2018","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0270","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/10717540490494050","article-title":"Intranasal bioavailability of insulin from carbopol-based gel spray in rabbits","volume":"11","author":"Najafabadi","year":"2004","journal-title":"Drug Deliv."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0275","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/10717544.2012.746401","article-title":"Insulin delivery through nasal route using thiolated microspheres","volume":"20","author":"Nema","year":"2013","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0280","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1002\/jps.20700","article-title":"In vivo evaluation of a nasal insulin delivery system based on thiolated chitosan","volume":"95","author":"Krauland","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125803","article-title":"Three-dimensional bioprinted gelatin methacryloyl scaffold: a versatile platform for nasal cell culture and drug testing applications","volume":"681","author":"Wong","year":"2025","journal-title":"Int. J. Pharm."},{"issue":"12","key":"10.1016\/j.ijbiomac.2025.148663_bb0290","doi-asserted-by":"crossref","first-page":"13077","DOI":"10.1007\/s12274-023-6026-y","article-title":"Intranasal administration nanosystems for brain-targeted drug delivery","volume":"16","author":"Jiang","year":"2023","journal-title":"Nano Res"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0295","article-title":"Advances in polysaccharide-based formulations for intranasal drug delivery: a review","volume":"101","author":"Daku","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0300","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.xphs.2024.10.009","article-title":"Bioequivalence requirements for orally inhaled and nasal drug products and use of novel physiologically based biopharmaceutics modeling approaches for assessing in vivo performance","volume":"114","author":"Rachapally","year":"2025","journal-title":"J. Pharm. Sci."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148663_bb0305","doi-asserted-by":"crossref","first-page":"21236","DOI":"10.1021\/acsomega.4c10474","article-title":"Development and characterization of zein\/Eudragit composite nanoparticles for insulin intranasal delivery","volume":"10","author":"Moreira","year":"2025","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0310","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1227423","article-title":"Synthesis of an insulin-loaded mucoadhesive nanoparticle designed for intranasal administration: focus on new diffusion media","volume":"14","author":"Jamshidnejad-Tosaramandani","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0315","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ejps.2015.10.022","article-title":"In vitro characterization of insulin containing thiomeric microparticles as nasal drug delivery system","volume":"81","author":"Deutel","year":"2016","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0320","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.ejps.2013.04.027","article-title":"Amphiphilic glycopolymer nanoparticles as vehicles for nasal delivery of peptides and proteins","volume":"49","author":"Zheng","year":"2013","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148663_bb0325","first-page":"244","article-title":"Effects of polyamidoamine (PAMAM) dendrimers on the nasal absorption of poorly absorbable drugs in rats","volume":"393","author":"Dong","year":"2010","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0330","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1021\/bm800975j","article-title":"New generation of hybrid poly\/oligosaccharide nanoparticles as carriers for the nasal delivery of macromolecules","volume":"10","author":"Teijeiro-Osorio","year":"2009","journal-title":"Biomacromolecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0335","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbm.b.31161","article-title":"Chitosan-NAC nanoparticles as a vehicle for nasal absorption enhancement of insulin","volume":"88","author":"Wang","year":"2009","journal-title":"J Biomed Mater Res B Appl Biomater"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0340","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ejpb.2007.08.009","article-title":"Nasal absorption enhancement of insulin using PEG-grafted chitosan nanoparticles","volume":"68","author":"Zhang","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"13","key":"10.1016\/j.ijbiomac.2025.148663_bb0345","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1016\/j.biomaterials.2006.12.024","article-title":"A thermosensitive hydrogel based on quaternized chitosan and poly(ethylene glycol) for nasal drug delivery system","volume":"28","author":"Wu","year":"2007","journal-title":"Biomaterials"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0350","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1007\/s11095-007-9257-9","article-title":"Chitosan reduced gold nanoparticles as novel carriers for transmucosal delivery of insulin","volume":"24","author":"Bhumkar","year":"2007","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0355","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jconrel.2006.03.011","article-title":"Aminated gelatin microspheres as a nasal delivery system for peptide drugs: evaluation of in vitro release and in vivo insulin absorption in rats","volume":"113","author":"Wang","year":"2006","journal-title":"J. Control. Release"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0360","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0378-5173(01)00708-6","article-title":"Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides","volume":"222","author":"Illum","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb0365","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1081\/DDC-100102275","article-title":"The relationship between the rigidity of the liposomal membrane and the absorption of insulin after nasal administration of liposomes modified with an enhancer containing insulin in rabbits","volume":"25","author":"Muramatsu","year":"1999","journal-title":"Drug Dev. Ind. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0370","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.2042-7158.1985.tb05024.x","article-title":"Enhancement of nasal absorption of insulin and calcitonin using polyacrylic acid gel","volume":"37","author":"Morimoto","year":"1985","journal-title":"J. Pharm. Pharmacol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0375","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1039\/C6MD00580B","article-title":"Recent trends in smart and flexible three-dimensional cross-linked polymers: synthesis of chitosan-ZnO nanocomposite hydrogels for insulin drug delivery","volume":"8","author":"El-Mekawy","year":"2017","journal-title":"MedChemComm"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0380","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.jconrel.2017.09.003","article-title":"Potential of insulin nanoparticle formulations for oral delivery and diabetes treatment","volume":"264","author":"Wong","year":"2017","journal-title":"J. Control. Release"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0385","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1021\/bm9001377","article-title":"Chitosan-alginate blended nanoparticles as carriers for the transmucosal delivery of macromolecules","volume":"10","author":"Goycoolea","year":"2009","journal-title":"Biomacromolecules"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0390","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/1061186X.2017.1400552","article-title":"The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation","volume":"26","author":"Wong","year":"2018","journal-title":"J. Drug Target."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb0395","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1023\/A:1018908705446","article-title":"Enhancement of nasal absorption of insulin using chitosan nanoparticles","volume":"16","author":"Fern\u00e1ndez-Urrusuno","year":"1999","journal-title":"Pharm. Res."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0400","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/02652040400015403","article-title":"Nasal delivery of insulin using chitosan microspheres","volume":"21","author":"Varshosaz","year":"2004","journal-title":"J. Microencapsul."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0405","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1023\/A:1015896405389","article-title":"Absorption enhancing effect of cyclodextrins on intranasally administered insulin in rats","volume":"8","author":"Merkus","year":"1991","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0410","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1023\/A:1015847604654","article-title":"Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations","volume":"9","author":"Shao","year":"1992","journal-title":"Pharm. Res."},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0415","doi-asserted-by":"crossref","first-page":"3100","DOI":"10.1248\/cpb.40.3100","article-title":"Enhancing effect of cyclodextrins on nasal absorption of insulin and its duration in rabbits","volume":"40","author":"Watanabe","year":"1992","journal-title":"Chem. Pharm. Bull."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0420","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1023\/A:1011073008325","article-title":"Mutual inhibition of the insulin absorption-enhancing properties of dodecylmaltoside and dimethyl-\u03b2-cyclodextrin following nasal administration","volume":"18","author":"Ahsan","year":"2001","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0425","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2012.05.013","article-title":"Phenylboronic acid-functionalized glycopolymeric nanoparticles for biomacromolecules delivery across nasal respiratory","volume":"82","author":"Zhang","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148663_bb0430","doi-asserted-by":"crossref","first-page":"5188","DOI":"10.3390\/molecules25215188","article-title":"Shortcut approaches to substance delivery into the brain based on intranasal administration using nanodelivery strategies for insulin","volume":"25","author":"Tashima","year":"2020","journal-title":"Molecules"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0435","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.carbpol.2012.02.060","article-title":"pH- and glucose-sensitive glycopolymer nanoparticles based on phenylboronic acid for triggered release of insulin","volume":"89","author":"Wang","year":"2012","journal-title":"Carbohydr. Polym."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0440","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jconrel.2019.05.029","article-title":"Advances in phenylboronic acid-based closed-loop smart drug delivery system for diabetic therapy","volume":"305","author":"Huang","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0445","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.carres.2017.04.006","article-title":"A glucose-sensitive block glycopolymer hydrogel based on dynamic boronic ester bonds for insulin delivery","volume":"445","author":"Cai","year":"2017","journal-title":"Carbohydr. Res."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0450","first-page":"305","article-title":"Preparation, in vitro and in vivo evaluation of polymeric nanoparticles based on hyaluronic acid\u2013poly(butyl cyanoacrylate) and D-\u03b1-tocopheryl polyethylene glycol 1000 succinate for tumor-targeted delivery of morin hydrate","volume":"10","author":"Abbad","year":"2015","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0455","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2023.106630","article-title":"A comprehensive review of advanced nasal delivery: specially insulin and calcitonin","volume":"192","author":"Luo","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0460","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jbiotec.2020.12.003","article-title":"Biocompatibility of magnetic nanoparticles coating with polycations using A549 cells","volume":"325","author":"Rozhina","year":"2021","journal-title":"J. Biotechnol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148663_bb0465","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijpharm.2017.12.036","article-title":"Microparticles, microcapsules and microspheres: a review of recent developments and prospects for oral delivery of insulin","volume":"537","author":"Wong","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0470","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/j.1464-5491.1992.tb01792.x","article-title":"Intranasal administration of insulin with phospholipid as absorption enhancer: pharmacokinetics in normal subjects","volume":"9","author":"Drejer","year":"1992","journal-title":"Diabet. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0475","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.cocis.2012.06.001","article-title":"Microemulsions as delivery systems","volume":"17","author":"Fanun","year":"2012","journal-title":"Curr. Opin. Colloid Interface Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104865","article-title":"Ciliary beat frequency of in vitro human nasal epithelium measured with simple high-speed microscopy is applicable for safety studies of nasal drug formulations","volume":"66","author":"Tratnjek","year":"2020","journal-title":"Toxicol. In Vitro"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0485","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.3390\/pharmaceutics13111750","article-title":"In vitro ciliotoxicity and cytotoxicity testing of repeated chronic exposure to topical nasal formulations for safety studies","volume":"13","author":"Tratnjek","year":"2021","journal-title":"Pharmaceutics"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0490","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1089\/jamp.2023.0041","article-title":"Practical considerations in dose extrapolation from animals to humans","volume":"37","author":"Hickey","year":"2024","journal-title":"J. Aerosol Med. Pulm. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0495","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.122024","article-title":"Validation of a cell-integrated next-generation impactor to assess in vitro drug transport of physiologically relevant aerosolised particles","volume":"624","author":"Wong","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0500","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121989","article-title":"Development of excipient-free inhalable co-spray-dried tobramycin and diclofenac formulations for cystic fibrosis using two- and three-fluid nozzles","volume":"624","author":"Marasini","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0505","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/17425247.2022.2026922","article-title":"Combining experimental and computational techniques to understand and improve dry-powder inhalers","volume":"19","author":"Chaugule","year":"2022","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.122667","article-title":"Microfluidics assembly of inhalable liposomal ciprofloxacin characterised by an innovative in vitro pulmonary model","volume":"635","author":"Zhang","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0515","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ejpb.2007.12.001","article-title":"Effective insulin delivery using starch nanoparticles as a potential trans-nasal mucoadhesive carrier","volume":"69","author":"Jain","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0520","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1248\/bpb.28.510","article-title":"Effect of aminated gelatin on the nasal absorption of insulin in rats","volume":"28","author":"Seki","year":"2005","journal-title":"Biol. Pharm. Bull."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0525","doi-asserted-by":"crossref","first-page":"852","DOI":"10.3390\/pharmaceutics13060852","article-title":"Spray freeze-dried Lyospheres\u00ae for nasal administration of insulin","volume":"13","author":"Serim","year":"2021","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15010207","article-title":"Recent advances in intranasal liposomes for drug, gene, and vaccine delivery","volume":"15","author":"Duong","year":"2023","journal-title":"Pharmaceutics"},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148663_bb0535","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ijpharm.2018.07.041","article-title":"Recent advancements in oral administration of insulin-loaded liposomal drug delivery systems for diabetes mellitus","volume":"549","author":"Wong","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0540","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1248\/cpb.40.1569","article-title":"Permeability of insulin entrapped in liposome through the nasal mucosa of rabbits","volume":"40","author":"Maitani","year":"1992","journal-title":"Chem. Pharm. Bull."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0545","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1039\/D0NR06104B","article-title":"Layer-by-layer coated nanoliposomes for oral delivery of insulin","volume":"13","author":"Zhang","year":"2021","journal-title":"Nanoscale"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0550","article-title":"Insulin-loaded liposomes functionalized with cell-penetrating peptides: influence on drug release and permeation through porcine nasal mucosa","volume":"622","author":"de Souza Von","year":"2021","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0555","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfa.2024.134073","article-title":"Design of glycol chitosan-decorated liposomes for the intranasal delivery of hydrophilic substances: physicochemical and in vitro\/in vivo biological assessment","volume":"693","author":"Vasilieva","year":"2024","journal-title":"Colloids Surf. A Physicochem. Eng. Asp."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0560","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/1556-276X-9-247","article-title":"Dendrimers: synthesis, applications, and properties","volume":"9","author":"Abbasi","year":"2014","journal-title":"Nanoscale Res. Lett."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0565","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-020-01652-w","article-title":"Combined therapy for Alzheimer\u2019s disease: tacrine and PAMAM dendrimers co-administration reduces the side effects of the drug without modifying its activity","volume":"21","author":"Igart\u00faa","year":"2020","journal-title":"AAPS PharmSciTech"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0570","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1007\/s44174-024-00229-6","article-title":"Molecular dynamics simulation of PAMAM dendrimer\u2013drug delivery systems","volume":"3","author":"Lisha","year":"2025","journal-title":"Biomed. Mater. Devices"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0575","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113908","article-title":"Emerging innate biological properties of nano-drug delivery systems: a focus on PAMAM dendrimers and their clinical potential","volume":"178","author":"Kheraldine","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0580","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1021\/acsbiomaterials.5c00336","article-title":"Changes in generations of PAMAM dendrimers and compositions of nucleic acid nanoparticles govern delivery and immune recognition","volume":"11","author":"Avila","year":"2025","journal-title":"ACS Biomater Sci. Eng."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112905","article-title":"Non-invasive intranasal administration route directly to the brain using dendrimer nanoplatforms: an opportunity to develop new CNS drugs","volume":"209","author":"Mignani","year":"2021","journal-title":"Eur. J. Med. Chem."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb0590","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1016\/j.xphs.2022.07.009","article-title":"PAMAM dendrimers: a review of methodologies employed in biopharmaceutical classification","volume":"111","author":"Guizze","year":"2022","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0595","doi-asserted-by":"crossref","DOI":"10.1016\/j.nwnano.2025.100094","article-title":"Engineering PAMAM dendrimers for optimized drug delivery","volume":"9","author":"Dehkordi","year":"2025","journal-title":"Nano Trends"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0600","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121203","article-title":"Deep eutectic systems: an overview of fundamental aspects, current understanding and drug delivery applications","volume":"610","author":"Chakraborty","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121811","article-title":"Deep eutectic solvents: recent advances in fabrication approaches and pharmaceutical applications","volume":"622","author":"Liu","year":"2022","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125509","article-title":"Natural deep eutectic solvents (NADES) in drug delivery systems: characteristics, applications, and future perspectives","volume":"675","author":"Li","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0615","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jconrel.2024.01.053","article-title":"Advances and future perspectives of intranasal drug delivery: a scientometric review","volume":"367","author":"Xu","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0620","article-title":"Malic acid-based deep eutectic solvent and its application in insulin\u2019s structural stability","volume":"20","author":"Kazhiyev","year":"2023","journal-title":"Res. Eng. Des."},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0625","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e29783","article-title":"Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery","volume":"10","author":"Javed","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0630","series-title":"Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions","first-page":"235","article-title":"Novel approaches in nasal in situ gel drug delivery","author":"Pagano","year":"2023"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0635","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ejpb.2007.05.008","article-title":"The addition of calcium ions to starch\/Carbopol mixtures enhances the nasal bioavailability of insulin","volume":"68","author":"Pringels","year":"2008","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0640","article-title":"Thermosensitive chitosan-\u03b2-glycerophosphate hydrogels as targeted drug delivery systems: an overview on preparation and their applications","volume":"2021","author":"Rahmanian-Devin","year":"2021","journal-title":"Adv. Pharmacol. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0645","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.msec.2017.04.109","article-title":"Enhanced gelation of chitosan\/\u03b2-sodium glycerophosphate thermosensitive hydrogel with sodium bicarbonate and biocompatibility evaluated","volume":"78","author":"Deng","year":"2017","journal-title":"Mater. Sci. Eng. C"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0650","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.actbio.2024.09.002","article-title":"Thermosensitive chitosan-based hydrogel: a vehicle for overcoming the limitations of nose-to-brain cell therapy","volume":"188","author":"Ojeda-Hern\u00e1ndez","year":"2024","journal-title":"Acta Biomater."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0655","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1039\/C2BM00132B","article-title":"A once-a-day dosage form for the delivery of insulin through the nasal route: in vitro assessment and in vivo evaluation","volume":"1","author":"Nazar","year":"2013","journal-title":"Biomater. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0660","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/bab.1917","article-title":"Synthesis and characterization of thermosensitive hydrogel based on quaternized chitosan for intranasal delivery of insulin","volume":"68","author":"Bahmanpour","year":"2021","journal-title":"Biotechnol. Appl. Biochem."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0665","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.134908","article-title":"A thermosensitive chitosan hydrogel: an attempt for the nasal delivery of dimethyl fumarate","volume":"278","author":"Nieto Gonz\u00e1lez","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0670","article-title":"The recent advancement in the chitosan-based thermosensitive hydrogel for tissue regeneration","volume":"86","author":"Abdollahi","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0675","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3109\/10717544.2013.849778","article-title":"Development of in situ gel for nasal delivery: design, optimization, in vitro and in vivo evaluation","volume":"21","author":"Galgatte","year":"2014","journal-title":"Drug Deliv."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb0680","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/jpp\/rgae090","article-title":"Advances in inhaler therapy for asthma and chronic obstructive pulmonary disease: a comprehensive review of Fostair\u2122 and Trimbow\u2122","volume":"76","author":"Foster","year":"2024","journal-title":"J. Pharm. Pharmacol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0685","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1080\/17425247.2023.2231850","article-title":"Advances in soft mist inhalers","volume":"20","author":"Komalla","year":"2023","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.123819","article-title":"In-situ gel: a smart carrier for drug delivery","volume":"652","author":"Garg","year":"2024","journal-title":"Int. J. Pharm."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0695","first-page":"1167","article-title":"In situ nasal gel drug delivery: a novel approach for brain targeting through the mucosal membrane","volume":"44","author":"Kaur","year":"2016","journal-title":"Artif. Cells Nanomed. Biotechnol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0700","first-page":"673","article-title":"In situ forming hydrogels based on chitosan for drug delivery and tissue regeneration","volume":"11","author":"Liu","year":"2016","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125192","article-title":"Application of polyvinyl alcohol\/chitosan copolymer hydrogels in biomedicine: a review","volume":"242","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140800","article-title":"Effects of neutralization and functionalization on chitosan\/gelatin\/polyvinyl alcohol scaffolds in insulin-producing cell culture","volume":"305","author":"S\u00e1nchez-Cardona","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0715","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.ijbiomac.2011.10.006","article-title":"Preparation and characterization of chitosan\u2013polyvinyl alcohol blend hydrogels for the controlled release of nano-insulin","volume":"50","author":"Zu","year":"2012","journal-title":"Int. J. Biol. Macromol."},{"issue":"2\u20133","key":"10.1016\/j.ijbiomac.2025.148663_bb0720","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0168-3659(99)00271-0","article-title":"Evaluation of starch\u2013maltodextrin\u2013Carbopol 974 P mixtures for the nasal delivery of insulin in rabbits","volume":"66","author":"Callens","year":"2000","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0725","article-title":"Impact of amino acids on the properties of nasal dry powders","volume":"87","author":"Baldelli","year":"2023","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0730","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15082119","article-title":"Optimizing absorption for intranasal delivery of drugs targeting the central nervous system using alkylsaccharide permeation enhancers","volume":"15","author":"Madden","year":"2023","journal-title":"Pharmaceutics"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0735","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40268-021-00360-5","article-title":"Improvement of intranasal drug delivery with Intravail\u00ae alkylsaccharide excipient as a mucosal absorption enhancer aiding in the treatment of conditions of the central nervous system","volume":"21","author":"Rabinowicz","year":"2021","journal-title":"Drugs R&D"},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0740","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3390\/pharmaceutics11030113","article-title":"Strategies to enhance drug absorption via nasal and pulmonary routes","volume":"11","author":"Ghadiri","year":"2019","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0745","series-title":"Peptide and Protein Delivery","first-page":"47","article-title":"Chapter 3 \u2013 Nasal delivery of peptides and proteins with chitosan and related mucoadhesive polymers","author":"Ritthidej","year":"2011"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0750","series-title":"Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions","first-page":"253","article-title":"Nasal delivery of high molecular weight drugs: Recent trends and clinical evidence","author":"Kahraman","year":"2023"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0755","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s13346-012-0069-z","article-title":"High efficiency intranasal drug delivery using Intravail\u00ae alkylsaccharide absorption enhancers","volume":"3","author":"Maggio","year":"2013","journal-title":"Drug Deliv. Transl. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0760","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejps.2007.02.002","article-title":"Nasal residence of insulin containing lyophilised nasal insert formulations, using gamma scintigraphy","volume":"31","author":"McInnes","year":"2007","journal-title":"Eur. J. Pharm. Sci."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0765","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1002\/jps.21977","article-title":"Reestablishment of the nasal permeability barrier to several peptides following exposure to the absorption enhancer tetradecyl-\u03b2-D-maltoside","volume":"99","author":"Arnold","year":"2010","journal-title":"J. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0770","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/10611869808997878","article-title":"Efficacy, safety and mechanism of cyclodextrins as absorption enhancers in nasal delivery of peptide and protein drugs","volume":"6","author":"Marttin","year":"1998","journal-title":"J. Drug Target."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0775","article-title":"Unraveling the role of chitosan for nasal drug delivery systems: a review","volume":"5","author":"Kaur","year":"2023","journal-title":"Carbohydr. Polym. Technol. Appl."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0780","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.3390\/pharmaceutics13081180","article-title":"Versatile nasal application of cyclodextrins: excipients and\/or actives?","volume":"13","author":"Rassu","year":"2021","journal-title":"Pharmaceutics"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0785","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1248\/bpb1978.10.624","article-title":"Studies on the promoting effects of medium chain fatty acid salts on the nasal absorption of insulin in rats","volume":"10","author":"Mishima","year":"1987","journal-title":"J. Pharmacobiodyn."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0790","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1248\/bpb.21.862","article-title":"Nasal insulin delivery in rabbits using soybean-derived sterylglucoside and sterol mixtures as novel enhancers in suspension dosage forms","volume":"21","author":"Ando","year":"1998","journal-title":"Biol. Pharm. Bull."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0795","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1248\/bpb.21.866","article-title":"High absorbency and subchronic morphologic effects on the nasal epithelium of a nasal insulin powder dosage form with a soybean-derived sterylglucoside mixture in rabbits","volume":"21","author":"Yamamoto","year":"1998","journal-title":"Biol. Pharm. Bull."},{"issue":"21","key":"10.1016\/j.ijbiomac.2025.148663_bb0800","doi-asserted-by":"crossref","first-page":"7419","DOI":"10.1073\/pnas.82.21.7419","article-title":"Nasal absorption of insulin: enhancement by hydrophobic bile salts","volume":"82","author":"Gordon","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ijbiomac.2025.148663_bb0805","first-page":"1051","article-title":"Nasal absorption enhancement of insulin by sodium deoxycholate in combination with cyclodextrins","volume":"22","author":"Zhang","year":"2001","journal-title":"Acta Pharmacol. Sin."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0810","doi-asserted-by":"crossref","first-page":"14451","DOI":"10.3390\/molecules200814451","article-title":"Absorption-enhancing effects of bile salts","volume":"20","author":"Moghimipour","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0815","series-title":"From Clone to Clinic","first-page":"323","article-title":"Intranasal delivery of insulin: Absorption enhancement by the fusidate derivative STDHF in rabbits and rats and effects on human nasal ciliary movement in vitro","author":"Verhoef","year":"1990"},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0820","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1023\/A:1018927710280","article-title":"Tolerability and absorption enhancement of intranasally administered octreotide by sodium taurodihydrofusidate in healthy subjects","volume":"9","author":"Kissel","year":"1992","journal-title":"Pharm. Res."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb0825","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1023\/A:1015904404442","article-title":"Absorption enhancement of intranasally administered insulin by sodium taurodihydrofusidate (STDHF) in rabbits and rats","volume":"6","author":"Deurloo","year":"1989","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0830","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jps.2600760502","article-title":"Effects of sodium taurodihydrofusidate on nasal absorption of insulin in sheep","volume":"76","author":"Longenecker","year":"1987","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0835","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0168-3659(88)90043-0","article-title":"Nasal drug delivery: an in vitro characterization of transepithelial electrical properties and fluxes in the presence or absence of enhancers","volume":"8","author":"Wheatley","year":"1988","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0840","doi-asserted-by":"crossref","first-page":"399","DOI":"10.2174\/156720106778559065","article-title":"Isolation, characterization and study of enhancing effects on nasal absorption of insulin in rat of the total saponin from Acanthophyllum squarrosum","volume":"3","author":"Sajadi Tabassi","year":"2006","journal-title":"Curr. Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0845","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1248\/bpb1978.12.31","article-title":"Promotion of nasal absorption of insulin by glycyrrhetinic acid derivatives. I","volume":"12","author":"Mishima","year":"1989","journal-title":"J. Pharmacobiodyn."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0850","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jconrel.2008.09.076","article-title":"Effect of cell-penetrating peptides on the nasal absorption of insulin","volume":"133","author":"El","year":"2009","journal-title":"J. Control. Release"},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0855","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1023\/A:1015872617511","article-title":"Effects of absorption enhancers on human nasal tissue ciliary movement in vitro","volume":"7","author":"Hermens","year":"1990","journal-title":"Pharm. Res."},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0860","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jps.2600800803","article-title":"Intranasal bioavailability of insulin powder formulations: effect of permeation enhancer-to-protein ratio","volume":"80","author":"Lee","year":"1991","journal-title":"J. Pharm. Sci."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0865","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1211\/jpp.61.02.0003","article-title":"Novel mucoadhesive nasal inserts based on chitosan\/hyaluronate polyelectrolyte complexes for peptide and protein delivery","volume":"61","author":"Luppi","year":"2009","journal-title":"J. Pharm. Pharmacol."},{"issue":"1\u20132","key":"10.1016\/j.ijbiomac.2025.148663_bb0870","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpharm.2004.05.007","article-title":"Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies","volume":"281","author":"Yu","year":"2004","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0875","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3109\/10717541003762888","article-title":"Nasal and rectal delivery of insulin with chitosan and N-trimethyl chitosan chloride","volume":"17","author":"du Plessis","year":"2010","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0880","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1023\/B:PHAM.0000012150.60180.e3","article-title":"Effect of chitosan on epithelial cell tight junctions","volume":"21","author":"Smith","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0885","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2147\/DDDT.S79383","article-title":"Paracellular permeation-enhancing effect of AT1002 C-terminal amidation in nasal delivery","volume":"9","author":"Song","year":"2015","journal-title":"Drug Des. Devel. Ther."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0890","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0024-3205(89)90291-9","article-title":"Effect of sodium glycocholate and polyoxyethylene-9-lauryl ether on the hydrolysis of varying concentrations of insulin in the nasal homogenates of the albino rabbit","volume":"45","author":"Hayakawa","year":"1989","journal-title":"Life Sci."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0895","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1023\/A:1015930821648","article-title":"Site dependence of absorption-promoting actions of Laureth-9, Na salicylate, Na\u2082EDTA, and aprotinin on rectal, nasal, and buccal insulin delivery","volume":"5","author":"Aungst","year":"1988","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0900","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0378-5173(95)04358-6","article-title":"Recovery of the nasal mucosa following Laureth-9 induced damage","volume":"130","author":"Zhou","year":"1996","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0905","series-title":"Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions","first-page":"169","article-title":"Nose-to-brain delivery of peptides and proteins","author":"Durgun","year":"2023"},{"issue":"9","key":"10.1016\/j.ijbiomac.2025.148663_bb0910","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/jphp.12749","article-title":"Modulating nasal mucosal permeation using metabolic saturation and enzyme inhibition techniques","volume":"69","author":"Dhamankar","year":"2017","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0915","series-title":"Nasal Drug Delivery: Formulations, Developments, Challenges, and Solutions","first-page":"25","article-title":"Drug absorption via the nasal route: Opportunities and challenges","author":"Amponsah","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120994","article-title":"Progress in nasal drug delivery systems","volume":"607","author":"Laffleur","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"2","key":"10.1016\/j.ijbiomac.2025.148663_bb0925","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.xphs.2015.11.015","article-title":"PEGylation of biopharmaceuticals: a review of chemistry and nonclinical safety information of approved drugs","volume":"105","author":"Turecek","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0930","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125166","article-title":"PEGylated solid lipid nanoparticles for the intranasal delivery of combination antiretroviral therapy composed of atazanavir and elvitegravir to treat NeuroAIDS","volume":"670","author":"Bazargani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0935","article-title":"PLGA nanoparticles for nasal drug delivery","volume":"95","author":"Alghareeb","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0940","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/152091503763816409","article-title":"An effective absorption behavior of insulin for diabetic treatment following intranasal delivery using porous spherical calcium carbonate in monkeys and healthy human volunteers","volume":"5","author":"Haruta","year":"2003","journal-title":"Diabetes Technol. Ther."},{"issue":"4","key":"10.1016\/j.ijbiomac.2025.148663_bb0945","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/dom.13615","article-title":"Nasal insulin administration does not affect hepatic glucose production at systemic fasting insulin levels","volume":"21","author":"Plomgaard","year":"2019","journal-title":"Diabetes Obes. Metab."},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb0950","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1111\/dom.13289","article-title":"Effects of intranasal insulin on endogenous glucose production in insulin-resistant men","volume":"20","author":"Xiao","year":"2018","journal-title":"Diabetes Obes. Metab."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0955","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1210\/jc.2017-01976","article-title":"Dose-dependent effects of intranasal insulin on resting-state brain activity","volume":"103","author":"Kullmann","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb0960","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.xjon.2023.11.020","article-title":"Safety of intranasal insulin administration in patients undergoing cardiovascular surgery: an open-label, nonrandomized, dose-escalation study","volume":"17","author":"Nakadate","year":"2024","journal-title":"JTCVS Open"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb0965","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00540-023-03233-0","article-title":"Intranasal insulin and cerebrospinal fluid glucose levels","volume":"37","author":"Omiya","year":"2023","journal-title":"J. Anesth."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb0970","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/193229681100500116","article-title":"Enhanced absorption of Nasulin\u2122, an ultrarapid-acting intranasal insulin formulation, using single nostril administration in normal subjects","volume":"5","author":"Stote","year":"2011","journal-title":"J. Diabetes Sci. Technol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2025.148663_bb0975","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1177\/193229681000400314","article-title":"Comparison pharmacokinetics of two concentrations (0.7% and 1.0%) of Nasulin, an ultra-rapid-acting intranasal insulin formulation","volume":"4","author":"Stote","year":"2010","journal-title":"J. Diabetes Sci. Technol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0980","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1177\/193229680800200613","article-title":"Pharamacokinetics and pharmacodynamics of intranasal insulin spray (Nasulin) administered to healthy male volunteers: influence of the nasal cycle","volume":"2","author":"Leary","year":"2008","journal-title":"J. Diabetes Sci. Technol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2025.148663_bb0985","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/BF00401839","article-title":"Intranasal insulin therapy: the clinical realities","volume":"38","author":"Hilsted","year":"1995","journal-title":"Diabetologia"},{"issue":"8","key":"10.1016\/j.ijbiomac.2025.148663_bb0990","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1046\/j.1464-5491.2001.00528.x","article-title":"Efficacy and tolerance of intranasal insulin administered during 4 months in severely hyperglycaemic type 2 diabetic patients with oral drug failure: a cross-over study","volume":"18","author":"Lalej-Bennis","year":"2001","journal-title":"Diabet. Med."},{"issue":"17","key":"10.1016\/j.ijbiomac.2025.148663_bb0995","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1056\/NEJM198504253121702","article-title":"Intranasal aerosolized insulin. Mixed-meal studies and long-term use in type I diabetes","volume":"312","author":"Salzman","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.ijbiomac.2025.148663_bb1000","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s13311-019-00822-4","article-title":"Intranasal insulin: a treatment strategy for addiction","volume":"17","author":"Kashyap","year":"2020","journal-title":"Neurotherapeutics"},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb1005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/dmrr.397","article-title":"Intranasally administered insulin intended for prevention of type 1 diabetes\u2014a safety study in healthy adults","volume":"19","author":"Kupila","year":"2003","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"Suppl. 1","key":"10.1016\/j.ijbiomac.2025.148663_bb1010","article-title":"718-P: Long-term safety of intranasal insulin (INI) in insulin-dependent type 2 diabetes (T2DM-IDDM): a safety substudy of memory advancement by intranasal insulin in type 2 diabetes (MemAID) trial","volume":"70","author":"Becerra","year":"2021","journal-title":"Diabetes"},{"issue":"7","key":"10.1016\/j.ijbiomac.2025.148663_bb1015","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1007\/s13346-024-01558-1","article-title":"Insulin delivery to the brain via the nasal route: unraveling the potential for Alzheimer\u2019s disease therapy","volume":"14","author":"Wong","year":"2024","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb1020","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120487","article-title":"The application of in vitro cellular assays for analysis of electronic cigarettes impact on the airway","volume":"298","author":"Wong","year":"2022","journal-title":"Life Sci."},{"issue":"2 Suppl","key":"10.1016\/j.ijbiomac.2025.148663_bb1025","first-page":"72","article-title":"Mechanisms and solutions for nasal drug delivery\u2014a narrative review","volume":"26","author":"Ulusoy","year":"2022","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.148663_bb1030","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ejpb.2023.06.015","article-title":"Engineered dry powders for the nose-to-brain delivery of transforming growth factor-beta","volume":"189","author":"Wong","year":"2023","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb1035","doi-asserted-by":"crossref","DOI":"10.1208\/s12249-022-02278-w","article-title":"Spray pattern and plume geometry testing and methodology: an IPAC-RS working group overview","volume":"23","author":"Baxter","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123345","article-title":"In situ hydrogel containing diazepam-loaded nanostructured lipid carriers (DZP-NLC) for nose-to-brain delivery: development, characterization and deposition studies in a 3D-printed human nasal cavity model","volume":"644","author":"Pina Costa","year":"2023","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.ijbiomac.2025.148663_bb1045","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A systematic review of commercial hybrid closed-loop automated insulin delivery systems","volume":"14","author":"Peacock","year":"2023","journal-title":"Diabetes Ther."},{"issue":"10","key":"10.1016\/j.ijbiomac.2025.148663_bb1050","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/dc24-0623","article-title":"Closed-loop insulin therapy for people with type 2 diabetes treated with an insulin pump: a 12-week multicenter, open-label randomized, controlled, crossover trial","volume":"47","author":"Borel","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ijbiomac.2025.148663_bb1055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133437","article-title":"Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes","volume":"275","author":"Adwani","year":"2024","journal-title":"Int. J. Biol. Macromol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025092207?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025092207?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T20:03:20Z","timestamp":1767211400000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025092207"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":211,"alternative-id":["S0141813025092207"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148663","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal delivery of insulin: An update on status quo and challenges for diabetes treatment","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.148663","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"148663"}}